StockData
Lakefront Biotherapeutics NV logo

Lakefront Biotherapeutics NV (LKFT) income statement

LKFTNasdaqPharmaceutical PreparationsAlso trades as GLPGF
Financials through fiscal 2025, year ended Dec 31, 2025Score 7/30
$33.31−0.08 (-0.24%)

Close on Nov 20, 2026Market cap $2.20BP/E 6.2Yield –

Lakefront Biotherapeutics NV financial ratios

See a number that looks wrong?